A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (11)

11030

Northshore Hosp / Cornell Univ, Manhasset

19104

Univ of Pennsylvania / HIV Clinic, Philadelphia

21205

Johns Hopkins Hosp, Baltimore

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

64108

Univ of Missouri at Kansas City School of Medicine, Kansas City

77030

Baylor College of Medicine, Houston

77550

Univ TX Galveston Med Branch, Galveston

85724

Univ of Arizona / Health Science Ctr, Tucson

87131

Univ of New Mexico Hlth Sciences Ctr / Dept of Med, Albuquerque

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002046 - A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC | Biotech Hunter | Biotech Hunter